From the bench to the bedside: ways to improve rituximab efficacy von Cartron, Guillaume, Watier, Hervé, Golay, Josée, Solal-Celigny, Philippe

Volltext

Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene von Cartron, Guillaume, Dacheux, Laurent, Salles, Gilles, Solal-Celigny, Philippe, Bardos, Pierre, Colombat, Philippe, Watier, Hervé

Volltext

Polymorphism in IgG Fc receptor gene FCGR3A and response to infliximab in Crohnʼs disease: a subanalysis of the ACCENT I study von Louis, Edouard J, Watier, Hervé E, Schreiber, Stefan, Hampe, Jochen, Taillard, François, Olson, Allan, Thorne, Nicole, Zhang, Hongyan, Colombel, Jean-Frédéric

Volltext

From the Gorgon's blood to Behring's Blutserumtherapie: A long path towards serum therapy von Lahaie, Yves‐Marie, Watier, Hervé

Volltext

Obinutuzumab: what is there to learn from clinical trials? von Cartron, Guillaume, Watier, Hervé

Volltext

Fatal infusion reactions to cetuximab: role of immunoglobulin e-mediated anaphylaxis von Pointreau, Yoann, Commins, Scott P, Calais, Gilles, Watier, Hervé, Platts-Mills, Thomas A E

Volltext

Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans? von Garraud, Olivier, Watier, Hervé

Volltext

Monoclonal Antibody Engineering and Design to Modulate FcRn Activities: A Comprehensive Review von Ramdani, Yanis, Lamamy, Juliette, Watier, Hervé, Gouilleux-Gruart, Valérie

Volltext

Rituximab mechanisms of action in B-CLL: a new piece of the puzzle von Watier, Hervé

Volltext

Theranostic of biopharmaceuticals von Chaigne, Benjamin, Watier, Hervé

Volltext

Evolutionary Story of the Low/Medium-Affinity IgG Fc Receptor Gene Cluster von Lejeune, Julien, Brachet, Guillaume, Watier, Hervé

Volltext

Pathophysiology of disk-related sciatica. I.—Evidence supporting a chemical component von Mulleman, Denis, Mammou, Saloua, Griffoul, Isabelle, Watier, Hervé, Goupille, Philippe

Volltext

Structure–function relationships of the variable domains of monoclonal antibodies approved for cancer treatment von Magdelaine-Beuzelin, Charlotte, Kaas, Quentin, Wehbi, Vanessa, Ohresser, Marc, Jefferis, Roy, Lefranc, Marie-Paule, Watier, Hervé

Volltext

Finding the Right Heavy Chains for Immunostimulatory Antibodies von Boulard, Pierre, Gouilleux-Gruart, Valérie, Watier, Hervé

Volltext

Insights into the IgG heavy chain engineering patent landscape as applied to IgG4 antibody development von Dumet, Christophe, Pottier, Jérémy, Gouilleux-Gruart, Valérie, Watier, Hervé

Volltext

Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients? von Chaigne, Benjamin, MD, Watier, Hervé, MD, PhD

Volltext

Why is there no biosimilar of Erbitux®? von Douez, Emmanuel, D’Atri, Valentina, Guillarme, Davy, Antier, Daniel, Guerriaud, Mathieu, Beck, Alain, Watier, Hervé, Foucault-Fruchard, Laura

Volltext

MAbTope: A Method for Improved Epitope Mapping von Bourquard, Thomas, Musnier, Astrid, Puard, Vincent, Tahir, Shifa, Ayoub, Mohammed Akli, Jullian, Yann, Boulo, Thomas, Gallay, Nathalie, Watier, Hervé, Bruneau, Gilles, Reiter, Eric, Crépieux, Pascale, Poupon, Anne

Volltext

IgG1 Allotypes Influence the Pharmacokinetics of Therapeutic Monoclonal Antibodies through FcRn Binding von Ternant, David, Arnoult, Christophe, Pugnière, Martine, Dhommée, Christine, Drocourt, Daniel, Perouzel, Eric, Passot, Christophe, Baroukh, Nadine, Mulleman, Denis, Tiraby, Gérard, Watier, Hervé, Paintaud, Gilles, Gouilleux-Gruart, Valérie

Volltext

FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population von Lejeune, Julien, Piegu, Benoit, Gouilleux-Gruart, Valérie, Ohresser, Marc, Watier, Hervé, Thibault, Gilles

Volltext